CYTK:NASDAQ
Cytokinetics, Inc.
$61.23
arrow_downward
-1.76%(-1.10) 1D
$61.23
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 23, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CYTK...
Open
$62.01
High
$62.44
Low
$60.89
Mkt. cap
8.51B
Avg. vol.
2.10M
Volume
985.63K
52-wk high
$88.31
52-wk low
$56.98
EPS
-$7.22
Beta
0.41
Shares outstanding
139.02M
No. of employees
673
Open
$62.01
High
$62.44
Low
$60.89
Mkt. cap
8.51B
Avg. vol.
2.10M
Volume
985.63K
52-wk high
$88.31
52-wk low
$56.98
EPS
-$7.22
Beta
0.41
Shares outstanding
139.02M
No. of employees
673
News stories
From web sources and news partners
Yahoo Finance
·
3 hours ago
Zero-Day Option Traders Are Betting Against Big S&P 500 Swings
Stocktwits
·
4 hours ago
Apollo’s Torsten Slok Warns AI Has Delivered ‘Zero Financial Payoff’ Outside Tech — 'AI Story Will Be Decided In The S&P 493, Not The Mag 7'
Cassandra Unchained | Michael Burry
·
19 hours ago
Foundations: The Fate of the S&P 500’s Worst Stocks, the Y2K Analogue, and Time for Small Caps?
Investor's Business Daily
·
1 hour ago
Futures Due; It's A Doom-And-Bloom Market
Profile
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function. Wikipedia
About Cytokinetics, Inc.
CEORobert I. Blum | Robert I. Blum
Employees673
Founded1997
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitecytokinetics.com